Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Pola describes dopamine reuptake inhibitors for Parkinson's disease

May 3, 1996

KY-455: Kyoto Pharm.'s ACAT/lipid peroxidation inhibitor

May 3, 1996

Vertex dedicates significant efforts to MDR-reversing agents

May 3, 1996

Eisai presents preliminary data on ER-34335

May 3, 1996

Selectin inhibitor GSC-150 effective in dermatitis models

May 3, 1996

MM-218 selected for development in emesis, diarrhea

April 26, 1996

OT-5226: New antidiabetic from Otsuka

April 26, 1996

Tanabe Seiyaku reports CCK-A antagonist for pancreatitis

April 26, 1996

Sanwa's SKK-47029 for disorders of gastric emptying

April 26, 1996

Terumo presents two new fibrinogen receptor antagonists

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...